First Time Loading...

Selecta Biosciences Inc
NASDAQ:SELB

Watchlist Manager
Selecta Biosciences Inc Logo
Selecta Biosciences Inc
NASDAQ:SELB
Watchlist
Price: 0.7465 USD 5.14%
Updated: May 1, 2024

Selecta Biosciences Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Selecta Biosciences Inc
Revenue Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Selecta Biosciences Inc
NASDAQ:SELB
Revenue
$48.7m
CAGR 3-Years
94%
CAGR 5-Years
296%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Revenue
$54.3B
CAGR 3-Years
6%
CAGR 5-Years
11%
CAGR 10-Years
11%
Gilead Sciences Inc
NASDAQ:GILD
Revenue
$27.1B
CAGR 3-Years
3%
CAGR 5-Years
4%
CAGR 10-Years
9%
Amgen Inc
NASDAQ:AMGN
Revenue
$28.2B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
4%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Revenue
$9.9B
CAGR 3-Years
17%
CAGR 5-Years
26%
CAGR 10-Years
23%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Revenue
$13.1B
CAGR 3-Years
16%
CAGR 5-Years
14%
CAGR 10-Years
20%

See Also

What is Selecta Biosciences Inc's Revenue?
Revenue
48.7m USD

Based on the financial report for Jun 30, 2023, Selecta Biosciences Inc's Revenue amounts to 48.7m USD.

What is Selecta Biosciences Inc's Revenue growth rate?
Revenue CAGR 5Y
296%

Over the last year, the Revenue growth was -62%. The average annual Revenue growth rates for Selecta Biosciences Inc have been 94% over the past three years , 296% over the past five years .